Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for In-process Quality Control

Posted on By

SOP for In-process Quality Control

Standard Operating Procedure for In-process Quality Control

1) Purpose

This SOP outlines the procedures for monitoring and controlling the quality of pharmaceutical products during the manufacturing process to ensure they meet specified standards and regulatory requirements.

2) Scope

This SOP applies to all in-process quality control activities conducted during the manufacturing of pharmaceutical products within the company.

3) Responsibilities

The Quality Control (QC) department is responsible for implementing and maintaining this SOP. The production staff is responsible for adhering to the in-process quality control procedures outlined in this SOP.

4) Procedure

4.1 Preparation for In-process Quality Control

  1. Review the batch production record (BPR) and identify critical control points (CCPs) for in-process testing.
  2. Ensure that all necessary equipment and materials are available and calibrated before starting the in-process tests.
See also  SOP for Quality Assurance Audits

4.2 In-process Testing

  1. Conduct in-process tests at specified intervals as outlined in the BPR. Typical tests may include weight variation, hardness, and uniformity of dosage units.
  2. Document all test results in the in-process control records (IPCR).
  3. Compare the results against predefined specifications to ensure they meet quality standards.

4.3 Handling Deviations

  1. Identify and document any deviations observed during in-process testing.
  2. Investigate the root cause of deviations and implement corrective actions to prevent recurrence.
  3. Record all deviations and corrective actions in the deviation report.

4.4

Final In-process Review

  1. Review all in-process test results and deviation reports at the end of the production batch.
  2. Approve the batch for further processing if all results meet the specified criteria.
  3. Quarantine and investigate the batch if any results do not meet the criteria.
See also  Quality Assurance: SOP for Root Cause Analysis in Gels Production

4.5 Documentation and Records

  1. Maintain complete and accurate records of all in-process tests, results, and deviations.
  2. Ensure that all documentation is readily accessible for audits and reviews.

5) Abbreviations, if any

QC: Quality Control
BPR: Batch Production Record
CCP: Critical Control Point
IPCR: In-process Control Records

6) Documents, if any

Batch Production Records, In-process Control Records, Deviation Reports

7) Reference, if any

Regulatory guidelines such as FDA, EMA, ICH Q8 (Pharmaceutical Development), and ICH Q10 (Pharmaceutical Quality System)

8) SOP Version

Version 1.0

Quality Assurance Tags:Batch Record Review SOP, CAPA SOP (Corrective and Preventive Actions), Change Control Management SOP, Cleaning Validation SOP, Documentation Control SOP, Equipment Qualification SOP, Finished Product Quality Assurance, Good Documentation Practices SOP, Handling Deviations SOP, In-process Quality Control SOP, Internal Quality Audits SOP, Out-of-Specification SOP, Packaging Material Quality Control, Pharmaceutical quality assurance SOP, Process Validation SOP, Product Complaint Handling SOP, Product Recall Management SOP, Quality Assurance Audits SOP, Quality Control Sample Management, Quality Risk Management SOP, Serialization and Traceability SOP, SOP for Raw Material Quality Assurance, Supplier Qualification SOP, Training and Competency Assessment SOP, Vendor Audits SOP

Post navigation

Previous Post: SOP for Powder Density Testing
Next Post: SOP for Angle of Repose Testing

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version